Aanjaneya Lifecare IPO
Aanjaneya Lifecare IPO — date, price band, lot size & details 2011
Aanjaneya Lifecare listed on 27 May 2011 at ₹218, 6.8% below the ₹234 issue price.
Aanjaneya Lifecare is an integrated pharmaceutical company making bulk drugs, finished dosages, herbal medicines and animal health products at Mahad near Mumbai. Its total income was Rs 169.36 crore in FY2010.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 09 May 2011
- Close 12 May 2011
- Allotment 19 May 2011
- Refund/credit TBA
- Listing 27 May 2011
Issue summary
The terms of the offer, as filed.
| IPO Dates | 9 to 12 May, 2011 |
|---|---|
| Price Band | ₹228 – ₹240 |
| Face Value | ₹10 |
| Lot Size | 25 Shares |
| Issue Size | ₹117 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | MUFG Intime India Private Limited |
| Min Investment | ₹ 5,850 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 25 shares at the ₹234 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 25 | ₹5,850 |
| Retail (max) | 34 | 850 | ₹1,98,900 |
| S-HNI (min) | 35 | 875 | ₹2,04,750 |
| S-HNI (max) | 170 | 4,250 | ₹9,94,500 |
| B-HNI (min) | 171 | 4,275 | ₹10,00,350 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01Total income rose from Rs 22.38 crore in FY2008 to Rs 169.36 crore in FY2010, and was Rs 292.58 crore in ten months to January 2011.
- 02Profit after tax rose from Rs 2.32 crore in FY2008 to Rs 15.08 crore in FY2010.
- 03Rs 26.55 crore of the issue was for an anti cancer API facility.
- 04Net worth rose from Rs 4.29 crore in FY2008 to Rs 129.42 crore on 31 January 2011.
Risks · 5
- 01Total borrowing rose from Rs 12.44 crore in FY2008 to Rs 118.38 crore on 31 January 2011.
- 02Growth was extremely fast from a tiny base of Rs 22.38 crore in FY2008, which is hard to sustain.
- 03All its manufacturing is at Mahad, where most of the new blocks, including Rs 14.80 crore for a cGMP block, are planned.
- 04Pharma plants face regulatory inspections, and cytotoxic APIs are hard to make safely; R&D needed Rs 19.08 crore.
- 05Promoter holding fell from 73.25% before the issue to 44.13% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Aanjaneya Lifecare offer document.
| Metric | 31 Jan 2011 | 31 Mar 2010 | 31 Mar 2009 | 31 Mar 2008 |
|---|---|---|---|---|
| Assets | 293.48 | 134.76 | 60.70 | 27.60 |
| Total Income | 292.58 | 169.36 | 91.16 | 22.38 |
| Profit After Tax | 31.05 | 15.08 | 5.11 | 2.32 |
| NET Worth | 129.42 | 49.71 | 12.31 | 4.29 |
| Reserves and Surplus | 121.85 | 43.94 | 7.36 | 2.29 |
| Total Borrowing | 118.38 | 59.69 | 37.63 | 12.44 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Aanjaneya Lifecare RHP.
Where the money goes
₹108.58 Cr of the issue is earmarked to named objects.
About the company
Its portfolio includes bulk drugs, finished dosage forms, herbal medicines, inhalers, lozenges and animal health products.
Its manufacturing facility at Mahad near Mumbai makes high end alkaloids, quinine salts, veterinary APIs and cytotoxic APIs.
The IPO was Rs 117 crore and was entirely fresh issue at Rs 234, within the Rs 228 to Rs 240 band. The money was for an anti cancer API facility, a cGMP API block, R&D expansion and a quality control block at Mahad.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Aanjaneya Lifecare IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
IDBI Capital Markets & Securities Ltd.
42 issues handledBest listing: Route Mobile (+104.9%). Weakest: Bharat Dynamics (-13.6%).
Anand Rathi Advisors Ltd
30 issues handledBest listing: Paras Defence & Space Technologies (+168.0%). Weakest: Indus Fila (-6.5%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Aanjaneya Lifecare?
The current Grey Market Premium is ₹0.
What is the Aanjaneya Lifecare IPO price band?
₹228 to ₹240, on a face value of ₹10.
When is the allotment?
The basis of allotment is 19 May 2011, with listing on 27 May 2011.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
